Study of Blood Samples From Newborns With Down Syndrome
Conditions
Down Syndrome | Leukemia
What is the purpose of this trial?
RATIONALE: Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.
PURPOSE: This research study is looking at blood samples from newborns with Down syndrome.
Participation Guidelines
- Age:
- Up to 1 Year
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Children's Oncology Group
National Cancer Institute (NCI) - Dates:
- February 2009
- Last Updated:
- December 21, 2011
- Study HIC#:
- 1112009391
Clinicaltrials.gov ID: NCT00959283
For more information about this trial, contact:
Investigator
Nina Kadan-Lottick, MD
Principal Investigator
